Abstract
Pioneering studies on the ability of extracts from decalcified bone matrix to promote ectopic bone and cartilage formation [1] led to searches for the identity of these morphogens which define skeletal patterning. With the advent of powerful methods for protein purification, capability to determine amino acid sequences on small amounts of protein and DNA cloning, bone morphogenetic proteins (BMPs) were discovered [2–4]. The amino acid sequences predicted from their cDNA sequences revealed that BMP-2, BMP-3 and BMP-4 (BMP-1 is a member of the astacin family of metalloproteases) are members of the TGF-13 superfamily, which also includes the TGF-βs and activins [5]. Mainly through their sequence homology with other BMPs approximately 20 members in the BMP subgroup have now been identified and can be divided in multiple groups of structurally related proteins, e.g. BMP2 and BMP-4 are highly related, BMP-6, BMP-7 and BMP-8 form another subgroup, and growth and differentiation factor (GDF)-5 (also termed cartilage-derived morphogenetic protein (CDMP)-1, GDF-7 (also termed CDGF-2) and GDF-6 are similar to each other.In vitroBMPs were found to have potent effects on various cells implicated in cartilage and bone formation, e.g. induce proteoglycan synthesis in chondroblasts and stimulate alkaline phosphatase activity and type I collagen synthesis in osteoblasts [4]. When injected into muscle of rats, BMPs can induce a biological cascade of cellular events leading to ectopic bone formation [3, 4]. GDF-5, GDF-6 and GDF-7 induce more efficiently tendon and cartilage-like structures[6, 7]. Preclinical studies of certain BMPs in primates and other mammals have demonstrated their effectiveness in restoring large segmental bone defects [8, 9].
Keywords
- Connective Tissue Growth Factor
- Smad Protein
- Bone Morphogenetic Protein Receptor
- Mesenchymal Precursor Cell
- Cleidocranial Dysplasia
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Urist MR (1965) Bone: formation by autoinduction.Science150: 893–899
Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA (1988) Novel regulators of bone formation: molecular clones and activities.Science242: 1528–1534
Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF, White KH, Coughlin JE, Tucker MM, Pang RH et al (1992) Recombinant human osteogenic protein-1 (hOP-1) induces new bone formationin vivowith a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiationin vitro. J Biol Chem267: 20352–20362
Vukicevic S, Luyten FP, Reddi AH (1989) Stimulation of the expression of osteogenic and chondrogenic phenotypesin vitroby osteogenin.Proc Natl Acad Sci USA86: 8793–8797
Massagué J (1990) The transforming growth factor-n family.Annu Rev Cell Biol6:597–641
Hotten GC, Matsumoto T, Kimura M, Bechtold RF, Kron R, Ohara T, Tanaka H, Satoh Y, Okazaki M, Shirai T et al (1996) Recombinant human growth, differentiation factor 5 stimulates mesenchyme aggregation and chondrogenesis responsible for the skeletal development of limbs.Growth Factors13: 65–74
Wolfman NM, Hattersley G, Cox K, Celeste AJ, Nelson R, Yamaji N, Dube JL, DiBlasio-Smith E, Nove J, Song JJ et al (1997) Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-β gene family.J Clin Invest100: 321–330
Reddi AH (1994) Symbiosis of biotechnology and biomaterials: applications in tissue engineering of bone and cartilage. JCell Biochem56: 192–195
Reddi AH (1998) Role of morphogenetic proteins in skeletal tissue engineering and regeneration.Nat Biotechnol16: 247–52
Cunningham NS, Paralkar V, Reddi AH (1992) Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor (31 mRNA expression.Proc Natl Acad Sci USA89: 11740–11744
Hogan BL (1996) Bone morphogenetic proteins in development.Curr Opin Genet Dev6: 432–438
Goumans M-J, Mummery C (2000) Functional analysis of the TGFI3 receptor, Smad pathway through gene ablation in miceInt J Dev Biol44: 253–265
Kingsley DM, Bland AE, Grubber JM, Marker PC, Russell LB, Copeland NG, Jenkins NA (1992) The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGFβ superfamily.Cell71: 399–410
Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM, Lee SJ (1994) Limb alterations in brachypodism mice due to mutations in a new member of the TGFβ-superfamily.Nature368: 639–643
McPherron AC, Lee SJ (1997) Double muscling in cattle due to mutations in the myostatin gene.Proc Natl Acad Sci USA94: 12457–12461
Thomas JT, Lin K, Nandedkar M, Camargo M, Cervenka J, Luyten FP (1996) A human chondrodysplasia due to a mutation in a TGF-(3 superfamily member.Nat Genet12: 315–317
Massagué J (1998) TGF-13 signal transduction.Annu Rev Biochem67: 753–791
Heldin C-H, Miyazono K, ten Dijke P (1997) TGF-3 signalling from cell membrane to nucleusviaSmad proteins.Nature390: 465–471
Mathews LS, Vale WW (1991) Expression cloning of an activin receptor, a predicted transmembrane serine kinase.Cell65: 973–982
Lin HY, Wang X-F, Ng-Eaton E, Weinberg RA, Lodish HF (1992) Expression cloning of the TGF-13 type II receptor, a functional transmembrane serine, threonine kinase.Cell68: 775–785
Ebner R, Chen RH, Shum L, Lawler S, Zioncheck TF, Lee A, Lopez AR, Derynck R (1993) Cloning of a type I TGF-(3 receptor and its effect on TGF-13 binding to the type II receptor.Science260: 1344–1348
Attisano L, Cárcamo J, Ventura F, Weis FM, Massagué J, Wrana JL (1993) Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors.Cell75: 671–680
Franzén P, ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin C-H, Miyazono K (1993) Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor.Cell75: 681–692
ten Dijke P, Yamashita H, Sampath TK, Reddi AH, Estevez M, Riddle DL, Ichijo H, Heldin C-H, Miyazono K (1994) Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.J Biol Chem269: 16985–16988
ten Dijke P, Yamashita H, Ichijo H, Franzén P, Laiho M, Miyazono K, Heldin C-H (1994) Characterization of type I receptors for transforming growth factor-3 and activin.Science264: 101–104
Nohno T, Ishikawa T, Saito T, Hosokawa K, Noji S, Wolsing DH, Rosenbaum JS (1995) Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors.J Biol Chem270: 22522–22526
Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, Heldin CH, Miyazono K (1995) Cloning and characterization of a human type II receptor for bone morphogenetic proteins.Proc Natl Acad Sci USA92: 7632–7636
Liu F, Ventura F, Doody J, Massagué J (1995) Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs.Mol Cell Biol15: 3479–3486
Koenig BB, Cook JS, Wolsing DH, Ting J, Tiesman JP, Correa PE, Olson CA, Pecquet AL, Ventura F, Grant RA et al (1994) Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells.Mol Cell Biol14: 5961–5974
Yamashita H, ten Dijke P, Huylebroeck D, Sampath TK, Andries M, Smith JC, Heldin C-H, Miyazono K (1995) Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.J Cell Biol130: 217–226
ten Dijke P, Ichijo H, Franzen P, Schulz P, Saras J, Toyoshima H, Heldin C-H, Miyazono K (1993) Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine, threonine kinase activity.Oncogene8: 2879–2887
Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J (1994) Mechanism of activation of the TGF-13 receptor.Nature370: 341–347
Miettinen PJ, Ebner R, Lopez AR, Derynck R (1994) TGF-(3 induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors.J Cell Biol127: 2021–2036
Macías-Silva M, Hoodless PA, Tang SJ, Buchwald M, Wrana JL (1998) Specific activation of Smadl signaling pathways by the BMP7 type I receptor, ALK2.J Biol Chem273: 25628–25636
Armes NA, Smith JC (1997) The ALK-2 and ALK-4 activin receptors transduce distinct mesoderm-inducing signals during early Xenopus development but do not co-operate to establish thresholds.Development124: 3797–3804
Nishitoh H, Ichijo H, Kimura M, Matsumoto T, Makishima F, Yamaguchi A, Yamashita H, Enomoto S, Miyazono K (1996) Identification of type I and type II serine, threonine kinase receptors for growth, differentiation factor-5.J Biol Chem271: 21345–21352
Akiyama S, Katagiri T, Namiki M, Yamaji N, Yamamoto N, Miyama K, Shibuya H, Ueno N, Wozney JM, Suda T (1997) Constitutively active BMP type I receptors trans-duce BMP-2 signals without the ligand in C2C12 myoblasts.Exp Cell Res235: 362–369
Namiki M, Akiyama S, Katagiri T, Suzuki A, Ueno N, Yamaji N, Rosen V, Wozney JM, Suda T (1997) A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts.J BiolChem 272: 22046–22042
Chen D, Ji X, Harris MA, Feng JQ, Karsenty G, Celeste AJ, Rosen V, Mundy GR, Harris SE (1998) Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages.J Cell Biol142: 295–305
Fujii M, Takeda K, Imamura T, Aoki H, Sampath TK, Enomoto S, Kawabata M, Kato M, Ichijo H, Miyazono K (1999) Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation.Mol Biol Cell10: 3801–3813
Daluiski A, Engstrand T, Bahamonde ME, Gamer LW, Agius E, Steven SL. (2001) Bone morphogenetic protein-3 is a negative regulator of bone density.Nature Genetics27: 84–88
Gu Z, Reynolds EM, Song J, Lei H, Feijen A, Yu L, He W, MacLaughlin DT, van den Eijnden-van Raaij J, Donahoe PK et al (1999) The type I serine, threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo.Development126: 2551–2561
Verschueren K, Dewulf N, Goumans MJ, Lonnoy O, Feijen A, Grimsby S, Vande Spiegle K, Ten Dijke P, Morén A, Vanscheeuwijck P et al (1995) Expression of type I and type IB receptors for activin in midgestation mouse embryos suggests distinct functions in organogenesis.Mech Dev52: 109–123
Dewulf N, Verschueren K, Lonnoy O, Morén A, Grimsby S, Vande Spiegle K, Miyazono K, Huylebroeck D, ten Dijke P (1995) Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis.Endocrinology136: 2652–2663
Zou H, Wieser R, Massagué J, Niswander L (1997) Distinct roles of type I bone morphogenetic protein receptors in the formation and differentiation of cartilage. Genes Dev 11: 2191–2203
Yi SE, Daluiski A, Pederson R, Rosen V, Lyons KM (2000) The type I BMP receptor BMPRIB is required for chondrogenesis in the mouse limb.Development127: 621–630
Manova K, De L, Angeles M, Kalantry S, Giarre M, Attisano L, Wrana J, Bachvarova RF (1995) mRNAs for activin receptors II and IIB are expressed in mouse oocytes and in the epiblast of pregastrula and gastrula stage mouse embryos.Mech Dev49: 3–11.
Matzuk MM, Kumar TR, Bradley A (1995) Different phenotypes for mice deficient in either activins or activin receptor type II.Nature374 (6520): 356–360
Beppu H, Kawabata M, Hamamoto T, Chytil A, Minowa O, Noda T, Miyazono K (2000) BMP type II receptor is required for gastrulation and early development of mouse embryos.Dev Biol221: 249–258
Roelen BA, Goumans M-J, van Rooijen MA, Mummery CL (1997) Differential expression of BMP receptors in early mouse development.Int J Dev Biol41: 541–549
Yonemori K, Imamura T, Ishidou Y, Okano T, Matsunaga S, Yoshida H, Kato M, Sampath TK, Miyazono K, ten Dijke P et al (1997) Bone morphogenetic protein receptors and activin receptors are highly expressed in ossified ligament tissues of patients with ossification of the posterior longitudinal ligament.Am J Pathol150: 1335–1347
Sakou T, Onishi T, Yamamoto T, Nagamine T, Sampath Tk, ten Dijke P (1999) Localization of Smads, the TGF-13 family intracellular signaling components during endochondral ossification.J Bone Miner Res14: 1145–1152
Ishidou Y, Kitajima I, Obama H, Maruyama I, Murata F, Imamura T, Yamada N, ten Dijke P, Miyazono K, Sakou T (1995) Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation.J Bone Miner Res 10:1651–1659
Hayashi K, Ishidou Y, Yonemori K, Nagamine T, Origuchi N, Maeda S, Imamura T, Kato M, Yoshida H, Sampath TK et al (1997) Expression and localization of bone morphogenetic proteins (BMPs) and BMP receptors in ossification of the ligamentum flavum.Bone21: 23–30
Okano T, Ishidou Y, Kato M, Imamura T, Yonemori K, Origuchi N, Matsunaga S, Yoshida H, ten Dijke P, Sakou T (1997) Orthotopic ossification of the spinal ligaments of Zucker fatty rats: a possible animal model for ossification of the human posterior longitudinal ligament.J Orthop Res15: 820–829
Sakou T (1998) Bone morphogenetic proteins: from basic studies to clinical approaches. Bone 22: 591–603
Mishina Y, Suzuki A, Ueno N, Behringer RR (1995) Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis.Genes Dev9: 3027–3037
Winnier G, Blessing M, Labosky PA, Hogan BL (1995) Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse.Genes Dev9: 2105–2116
Oh SP, Li E (1997) The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse.Genes Dey 11:1812–1826
Song J, Oh SP, Schrewe H, Nomura M, Lei H, Okano M, Gridley T, Li E (1999) The type II activin receptors are essential for egg cylinder growth, gastrulation, and rostral head development in mice.Dev Biol213: 157–169
Gilboa L, Nohe A, Geissendorfer T, Sebald W, Henis YI, Knaus P (2000) Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine, threonine kinase receptors. MolBiol Cell11: 1023–1035
Wrana JL, Attisano L, Cárcamo J, Zentella A, Doody J, Laiho M, Wang X-F, Massagué J (1992) TGF 13 signals through a heteromeric protein kinase receptor complex. Cell71:1003–1014
Cárcamo J, Weis FM, Ventura F, Wieser R, Wrana JL, Attisano L, Massagué J (1994) Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor 13 and activin. MolCell Biol.14(6): 3810–3821.
Chen YG, Hata A, Lo RS, Wotton D, Shi Y, Pavletich N, Massagué J (1998) Determinants of specificity in TGF-13 signal transduction.Genes Dev12: 2144–2152
Feng X-H, Derynck R (1997) A kinase subdomain of transforming growth factor-3 (TGF-β) type I receptor determines the TGF-13 intracellular signaling specificity. EMBO J 16: 3912–3923
Persson U, Izumi H, Souchelnytskyi S, Itoh S, Grimsby S, Engström U, Heldin C-H, Funa K, ten Dijke P (1998) The L45 loop in type I receptors for TGF-13 family members is a critical determinant in specifying Smad isoform activation.FEBS Lett434: 83–87
Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA, Loyd JE, Nichols WC Trembath RC, Micheala A, Brannon CA (2000) Heterozygous germline mutations in BMPR2, encoding a TGF-(3 receptor, cause familial primary pulmonary hypertensionNat Genet26: 81–84
Machado RD, Pauciulo MW, Thomson JR, Lane KB, Morgan NV, Wheeler L, Phillips III, Newman J, Williams D, Galie N et al (2001) BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. AmJ Hum Genet68: 92–102
Thomson JR, Machado RD, Pauciulo MW, Morgan NV, Humbert M, Elliott GC, Ward K, Yacoub M, Mikhail G, Rogers P (2000) Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family.J Med Genet37: 741–745
Wilkins MR, Gibbs JS, Shovlin CL. (2000) A gene for primary pulmonary hypertensionLancet356: 1207–1208
Savage C, Das P, Finelli AL, Townsend SR, Sun CY, Baird SE, Padgett RW (1996)Caenorhabditis elegansgenes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factorβpathway components.Proc Natl Acad Sci USA93: 790–794
Sekelsky JJ, Newfeld SJ, Raftery LA, Chartoff EH, Gelbart WM (1995) Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function inDrosophila melanogaster. Genetics139: 1347–1358
Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone MA, Wrana JL (1997) The MAD-related protein Smad7 associates with the TGF(3 receptor and functions as an antagonist of TGFI3 signaling.Cell89: 1165–1173
Imamura T, Takase M, Nishihara A, Oeda E, Hanai J-I, Kawabata M, Miyazono K (1997) Smad6 inhibits signalling by the TGF-β superfamily.Nature389: 622–626
Nakao A, Afrakhte M, Morén A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin N-E, Heldin C-H et al (1997) Identification of Smad7, a TGF(3-inducible antagonist of TGF-β signalling.Nature389: 631–635
Lo RS, Chen YG, Shi Y, Pavletich NP, Massagué J (1998) The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF-13 receptors.EMBO J17:996–1005
Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL (1998) SARA, a FYVE domain protein that recruits Smad2 to the TGF13 receptor.Cell95: 779–791
Miura S, Takeshita T, Asao H, Kimura Y, Murata K, Sasaki Y, Hanai JI, Beppu H, Tsukazaki T, Wrana JL et al (2000) Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA.Mol Cell Biol20: 9346–9355
Abdollah S, Macías-Silva M, Tsukazaki T, Hayashi H, Attisano L, Wrana JL (1997) T(3RI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling.J Biol Chem272: 27678–27685
Kretzschmar M, Liu F, Hata A, Doody J, Massagué J (1997) The TGF-(3 family mediator Smadl is phosphorylated directly and activated functionally by the BMP receptor kinase.Genes Dev 11:984–995
Macías-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL (1996) MADR2 is a substrate of the TGF(3 receptor and its phosphorylation is required for nuclear accumulation and signaling.Cell87: 1215–1224
Souchelnytskyi S, Tamaki K, Engström U, Wernstedt C, ten Dijke P, Heldin C-H (1997) Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-13 signaling.J Biol Chem272: 28107–28115
Ebisawa T, Tada K, Kitajima I, Tojo K, Sampath TK, Kawabata M, Miyazono K, Imamura T (1999) Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation.J Cell Sci112: 3519–3527
Nishimura R, Kato Y, Chen D, Harris SE, Mundy GR, Yoneda T (1998) Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12.J Biol Chem273: 1872–1879
Tamaki K, Souchelnytskyi S, Itoh S, Nakao A, Sampath K, Heldin C-H, ten Dijke P (1998) Intracellular signaling of osteogenic protein-1 through Smad5 activation.J Cell Physiol177: 355–363
Lagna G, Hata A, Hemmati-Brivanlou A, Massagué J (1996) Partnership between DPC4 and SMAD proteins in TGF-13 signalling pathways.Nature383: 832–836
Correia JJ, Chacko BM, Lam SS, Lin K (2001) Sedimentation studies reveal a direct role of phosphorylation in Smad3:Smad4 homo-and hetero-trimerization.Biochemistry40: 1473–1482
Kawabata M, Inoue H, Hanyu A, Imamura T, Miyazono K (1998) Smad proteins exist as monomersin vivoand undergo homo-and hetero-oligomerization upon activation by serine, threonine kinase receptors. EMBOJ17: 4056–4065
Shi Y, Hata A, Lo RS, Massagué J, Pavletich NP (1997) A structural basis for mutational inactivation of the tumour suppressor Smad4.Nature388: 87–93
Xiao Z, Liu X, Lodish HF (2000) Importin 13 mediates nuclear translocation of Smad3.J Biol Chem275: 23425–23428
Xiao Z, Liu X, Henis YI, Lodish HF (2000) A distinct nuclear localization signal in the N terminus of Smad3 determines its ligand-induced nuclear translocation.Proc Natl Acad Sci USA97: 7853–7858
Pierreux CE, Nicolas FJ, Hill CS (2000) Transforming growth factor 13-independent shuttling of Smad4 between the cytoplasm and nucleus.Mol Cell Biol20: 9041–9054
Watanabe M, Masuyama N, Fukuda M, Nishida E (2000) Regulation of intracellular dynamics of Smad4 by its leucine-rich nuclear export signal.EMBO Reports 1:176–182
Massagué J, Wotton D (2000) Transcriptional control by the TGF-0, Smad signaling system. EMBO J 19: 1745–1754
ten Dijke P, Miyazono K, Heldin C-H. (2000) Signaling inputs converge on nuclear effectors in TGF-0 signaling.Trends Biochem Sci25: 64–70
Flanders KC, Kim ES, Roberts AB (2001) Immunohistochemical expression of smads 16 in the 15-day gestation mouse embryo: signaling by BMPs and TGF-13s.Dey Dyn220: 141–154
Zhu H, Kaysak P, Abdollah S, Wrana JL, Thomsen GH (1999) A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation.Nature400: 687–693
Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM (1998) Direct binding of Smad3 and Smad4 to critical TGF (3-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.EMBO J17: 3091–3100
Jonk LJ, Itoh S, Heldin C-H, ten Dijke P, Kruijer W (1998) Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-(3, activin, and bone morphogenetic protein-inducible enhancer.J Biol Chem273: 21145–21152
Yingling JM, Datto MB, Wong C, Frederick JP, Liberati NT, Wang X-F (1997) Tumor suppressor Smad4 is a transforming growth factor 0-inducible DNA binding protein.Mol Cell Biol17: 7019–7028
Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B, Kern SE (1998) Human Smad3 and Smad4 are sequence-specific transcription activators.Mol Cell1: 611–617
Brodin G, Åhgren A, ten Dijke P, Heldin C-H, Heuchel R (2000) Efficient TGF-13 induction of the Smad7 gene requires cooperation between AP-1, Spl, and Smad proteins on the mouse Smad7 promoter.J Biol Chem275: 29023–29030
Denissova NG, Pouponnot C, Long J, He D, Liu F (2000) Transforming growth factor 0-inducible independent binding of SMAD to the Smad7 promoter.Proc Natl Acad Sci USA97: 6397–6402
Nagarajan RP, Zhang J, Li W, Chen Y (1999) Regulation of Smad7 promoter by direct association with Smad3 and Smad4.J Biol Chem274: 33412–33418
Stopa M, Anhuf D, Terstegen L, Gatsios P, Gressner AM, Dooley S (2000) Participation of Smad2, Smad3, and Smad4 in transforming growth factorβ(TGF-0)-induced activation of Smad7. The TGF-I3 response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulationJ Biol Chem275: 29308–29317
von Gersdorff G, Susztak K, Rezvani F, Bitzer M, Liang D, Bottinger EP (2000) Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor β.J Biol Chem275: 11320–11326
Stroschein SL, Wang W, Luo K (1999) Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor (3-induced Smad-dependent transcriptional activation.J Biol Chem274: 9431–9441
Chen SJ, Yuan W, Lo S, Trojanowska M, Varga J (2000) Interaction of Smad3 with a proximal smad-binding element of the human a2(I) procollagen gene promoter required for transcriptional activation by TGF-(3.J Cell Physiol183: 381–392
Vindevoghel L, Lechleider RJ, Kon A, de Caestecker MP, Uitto J, Roberts AB, von Gersdorff G, Susztak K, Rezvani F, Bitzer M et al (2000) Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor P.J Biol Chem275: 11320–11326
Shi Y, Wang YF, Jayaraman L, Yang H, Massagué J, Pavletich NP (1998) Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-(3 signaling.Cell94: 585–594
Henningfeld KA, Rastegar S, Adler G, Knochel W (2000) Smad1 and Smad4 are components of the bone morphogenetic protein-4 (BMP-4)-induced transcription complex of the Xvent-2B promoter.J Biol Chem275: 21827–21835
Ishida W, Hamamoto T, Kusanagi K, Yagi K, Kawabata M, Takehara K, Sampath TK, Kato M, Miyazono K (2000) Smad6 is a Smad1, 5-induced Smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter.J Biol Chem275: 6075–6079
Kim J, Johnson K, Chen HJ, Carroll S, Laughon A (1997)DrosophilaMad binds to DNA and directly mediates activation of vestigial by Decapentaplegic.Nature388: 304–308
Kusanagi K, Inoue H, Ishidou Y, Mishima HK, Kawabata M, Miyazono K (2000) Characterization of a bone morphogenetic protein-responsive Smad-binding element.Mol Biol Cell11: 555–565.
Yoshida Y, Tanaka S, Umemori H, Minowa 0, Usui M, Ikematsu N, Hosoda E, Imamura T, Kuno J, Yamashita T (2000) Negative regulation of BMP, Smad signaling by Tob in osteoblasts.Cell103: 1085–1097
Derynck R, Zhang Y, Feng X-H (1998) Smads: transcriptional activators of TGF-(3 responses.Cell95: 737–740
Hata A, Seoane J, Lagna G, Montalvo E, Hemmati-Brivanlou A, Massagué J (2000) OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways.Cell100: 229–240
Hanai J-i, Chen LF, Kanno T, Ohtani-Fujita N, Kim WY, Guo WH, Imamura T, Ishidou Y, Fukuchi M, Shi MJ et al (1999) Interaction and functional cooperation of PEBP2, CBF with Smads. Synergistic induction of the immunoglobulin germline Ca promoter.J Biol Chem274: 31577–31582
Pardali E, Xie XQ, Tsapogas P, Itoh S, Arvanitidis K, Heldin C-H, ten Dijke P, Grundstrom T, Sideras P (2000) Smad and AML proteins synergistically confer transforming growth factor β1 responsiveness to human germ-line IgA genes.J Biol Chem275: 3552–3560
Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M (1997) Targeted disruption of Cbfal results in a complete lack of bone formation owing to maturational arrest of osteoblasts.Cell89: 755–764
Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G (1999) A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development.Genes Dey13: 1025–1036
Mundlos S, Mulliken JB, Abramson DL, Warman ML, Knoll JH, Olsen BR (1995) Genetic mapping of cleidocranial dysplasia and evidence of a microdeletion in one family.Hum Mol Genet4: 71–75
Zhang YW, Yasui N, Ito K, Huang G, Fujii M, Hanai J, Nogami H, Ochi T, Miyazono K, Ito Y (2000) A RUNX2, PEBP2aA, CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia.Proc Natl Acad Sci USA97: 10549–10554
Liu F, Hata A, Baker JC, Doody J, Carcámo J, Harland RM, Massagué J (1996) A human Mad protein acting as a BMP-regulated transcriptional activator.Nature381: 620–623
Meersseman G, Verschueren K, Nelles L, Blumenstock C, Kraft H, Wuytens G, Remade J, Kozak CA, Tylzanowski P, Niehrs C et al (1997) The C-terminal domain of Mad-like signal transducers is sufficient for biological activity in theXenopusembryo and transcriptional activation.Mech Dey61: 127–140
Pouponnot C, Jayaraman L, Massagué J (1998) Physical and functional interaction of SMADs and p300, CBP.J Biol Chem273: 22865–22868
Nakashima K, Yanagisawa M, Arakawa H, Kimura N, Hisatsune T, Kawabata M, Miyazono K, Taga T (1999) Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300.Science284: 479–482
Massagué J, Chen YG (2000) Controlling TGF-beta signaling.Genes Dey14: 627–644
Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, Massagué J, Niehrs C (1999) Silencing of TGF-(3 signalling by the pseudoreceptor BAMBI.Nature401: 480–485
Tsang M, Kim R, de Caestecker MP, Kudoh T, Roberts AB, Dawid IB (2000) Zebrafish nma is involved in TGF(3 family signaling.Genesis28: 47–57
Kretzschmar M, Doody J, Massagué J (1997) Opposing BMP and EGF signalling pathways converge on the TGF-(3 family mediator Smad1.Nature389: 618–622
Ishisaki A, Yamato K, Hashimoto S, Nakao A, Tamaki K, Nonaka K, ten Dijke P, Sugino H, Nishihara T (1999) Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein-and activin-mediated growth arrest and apoptosis in B cells.J Biol Chem274: 13637–13642
Kaysak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, Wrana JL (2000) Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF(3 receptor for degradation.Mol Cell6: 1365–1375
Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, Miyazono K (2001) Smurf1 interacts with transforming growth factor43 type I receptor through Smad7 and induces receptor degradation.J Biol Chem276: 12477–12480
Hata A, Lagna G, Massagué J, Hemmati-Brivanlou A (1998) Smad6 inhibits BMP, Smad1 signaling by specifically competing with the Smad4 tumor suppressor.Genes Dey12: 186–197
Bai S, Shi X, Yang X, Cao X (2000) Smad6 as a transcriptional corepressor.J Biol Chem275: 8267–8270
Kimura N, Matsuo R, Shibuya H, Nakashima K, Taga T (2000) BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. JBiol Chem275: 17647–17652
Luo K, Stroschein SL, Wang W, Chen D, Martens E, Zhou S, Zhou Q (1999) The Ski oncoprotein interacts with the Smad proteins to repress TGF(3 signaling.Genes Dey13: 2196–2206
Wang W, Mariani FV, Harland RM, Luo K (2000) Ski represses bone morphogenic protein signaling inXenopusand mammalian cellsProc Natl Acad Sci USA97: 14394–14399
Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K (1995) Identification of a member of the MAPKKK family as a potential mediator of TGF-13 signal transduction.Science270: 2008–2011
Yamaguchi K, Nagai S, Ninomiya-Tsuji J, Nishita M, Tamai K, Irie K, Ueno N, Nishida E, Shibuya H, Matsumoto K (1999) XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1–TAK1 in the BMP signaling pathway. EMBOJ18: 179–187
Sano Y, Harada J, Tashiro S, Gotoh-Mandeville R, Maekawa T, Ishii S (1999) ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-f3 signaling.J Biol Chem274: 8949–8957
Nakamura K, Shirai T, Morishita S, Uchida S, Saeki-Miura K, Makishima F (1999) p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth, differentiation factor-5 in ATDCS cells.Exp Cell Res250: 351–363
Ahrens M, Ankenbauer T, Schroder D, Hollnagel A, Mayer H, Gross G (1993) Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1, 2 cells induces differentiation into distinct mesenchymal cell lineages.DNA Cell Biol12: 871–880
Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T (1994) Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage.J Cell Biol127: 1755–1766
Maliakal JC, Asahina I, Hauschka PV, Sampath TK (1994) Osteogenic protein-1 (BMP-7) inhibits cell proliferation and stimulates the expression of markers characteristic of osteoblast phenotype in rat osteosarcoma (17, 2.8) cells.Growth Factors 11:227–234
Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, Wozney JM, Kim EG, Choi JY, Ryoo HM et al (2000) Runx2 is a common target of transforming growth factor 131 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12.Mol Cell Biol20: 8783–8792
Shi X, Yang X, Chen D, Chang Z, Cao X (1999) Smadl interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling.J Biol Chem274: 13711–13717
Yang X, Ji X, Shi X, Cao X (2000) Smad1 domains interacting with Hoxc-8 induce osteoblast differentiation.J Biol Chem275: 1065–1072
Hullinger TG, Pan Q, Viswanathan HL, Somerman MJ (2001) TGF13 and BMP-2 activation of the OPN promoter: roles of Smad-and Hox-binding elements.Exp Cell Res262: 69–74
Wan M, Shi X, Feng X, Cao X (2001) Transcriptional mechanisms of BMP-induced osteoprotegrin gene expression.J Biol Chem276: 10119–10125
Nakanishi T, Kimura Y, Tamura T, Ichikawa H, Yamaai Y, Sugimoto T, Takigawa M (1997) Cloning of a mRNA preferentially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA.Biochem Biophys Res Commun234: 206–210
Nishida T, Nakanishi T, Asano M, Shimo T, Takigawa M (2000) Effects of CTGF, Hcs24, a hypertrophie chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cellsin vitro. J Cell Physiol184: 197–206
Afrakhte M, Morén A, Jossan S, Itoh S, Sampath K, Westermark B, Heldin C-H, Heldin N-E, ten Dijke P (1998) Induction of inhibitory Smad6 and Smad7 mRNA by TGF-β family members.Biochem Biophys Res Commun249: 505–511
Takase M, Imamura T, Sampath TK, Takeda K, Ichijo H, Miyazono K, Kawabata M. (1998) Induction of Smad6 mRNA by bone morphogenetic proteins.Biochem Biophys Res Commun244: 26–29
Chalaux E, Lopez-Rovira T, Rosa JL, Bartrons R, Ventura F (1998) JunB is involved in the inhibition of myogenic differentiation by bone morphogenetic protein-2.J Biol Chem273: 537–543
Hollnagel A, Oehlmann V, Heymer J, Ruther U, Nordheim A (1999) Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells.J Biol Chem274: 19838–19845
Ogata T, Wozney JM, Benezra R, Noda M (1993) Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helixloop-helix molecule in osteoblast-like cells.Proc Natl Acad Sci USA90: 9219–9222
Moldes M, Lasnier F, Feve B, Pairault J, Djian P (1997) Id3 prevents differentiation of preadipose cells.Mol Cell Biol17: 1796–1804
Jen Y, Weintraub H, Benezra R (1992) Overexpression of Id protein inhibits the muscle differentiation program:in vivoassociation of Id with E2A proteins.Genes Dev6: 1466–1479
Melnikova IN, Christy BA (1996) Muscle cell differentiation is inhibited by the helixloop-helix protein Id3.Cell Growth Differ7: 1067–1079
Miyama K, Yamada G, Yamamoto TS, Takagi C, Miyado K, Sakai M, Ueno N, Shibuya H (1999) A BMP-inducible gene, dlx5, regulates osteoblast differentiation and mesoderm induction.Dev Biol208: 123–133
Acampora D, Merlo GR, Paleari L, Zerega B, Postiglione MP, Mantero S, Bober E, Barbieri O, Simeone A, Levi G (1999) Craniofacial, vestibular and bone defects in mice lacking the Distal-less-related gene DIxS.Development126: 3795–3809
Sirard C, Kim S, Mirtsos C, Tadich P, Hoodless PA, Itie A, Maxson R, Wrana JL, Mak TW (2000) Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor 13-related signaling.J Biol Chem275: 2063–2070
Satokata I, Ma L, Ohshima H, Bei M, Woo I, Nishizawa K, Maeda T, Takano Y, Uchiyama M, Heaney S et al (2000) Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation.Nat Genet24: 391–395
Service RF (2000) Tissue engineers build new bone.Science289: 1498–1500
Franceschi RT, Wang D, Krebsbach PH, Rutherford RB (2000) Gene therapy for bone formation:in vitroandin vivoosteogenic activity of an adenovirus expressing BMP7.J Cell Biochem78: 476–486
Fang J, Zhu YY, Smiley E, Bonadio J, Rouleau JP, Goldstein SA, McCauley LK, Davidson BL, Roessler BJ (1996) Stimulation of new bone formation by direct transfer of osteogenic plasmid genes.Proc Natl Acad Sci USA93: 5753–5758
Zhang H, Bradley A (1996) Mice deficient for BMP2 are nonviable and have defects in amnion, chorion and cardiac development.Development122: 2977–2986
Solloway MJ, Dudley AT, Bikoff EK, Lyons KM, Hogan BL, Robertson EJ (1998) Mice lacking Bmp6 function.Dev Genet22: 321–339
Luo G, Hofmann C, Bronckers AL, Sohocki M, Bradley A, Karsenty G (1995) BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning.Genes Dev9: 2808–2820
Dudley AT, Lyons KM, Robertson EJ (1995) A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye.Genes Dev9: 2795–2807
Solloway MJ, Robertson EJ (1999) Early embryonic lethality in BmpS;Bmp7 double mutant mice suggests functional redundancy within the 60A subgroup.Development126: 1753–1768
Zhao GQ, Deng K, Labosky PA, Liaw L, Hogan BL (1996) The gene encoding bone morphogenetic protein 8B is required for the initiation and maintenance of spermatogenesis in the mouse.Genes Dev10: 1657–1669
Galloway SM, McNatty KP, Cambridge LM, Laitinen MP, Juengel JL, Jokiranta TS, McLaren RJ, Luiro K, Dodds KG, Montgomery GW et al (2000) Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner.Nat Genet25: 279–283
Sirard C, de la Pompa JL, Elia A, Itie A, Mirtsos C, Cheung A, Hahn S, Wakeham A., Schwartz L, Kern SE et al (1998) The tumor suppressor gene Smad4, Dpc4 is required for gastrulation and later for anterior development of the mouse embryo.Genes Dev12: 107–119
Chang H, Huylebroeck D, Verschueren K, Guo Q, Matzuk MM, Zwijsen A (1999) SmadS knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects.Development126: 1631–1642
Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C et al (1996) Increased bone formation in osteocalcin-deficient mice.Nature382: 448–452
Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL (1998) Altered wound healing in mice lacking a functional osteopontin gene (sppl).J Clin Invest101: 1468–1478
Yoshitake H, Riffling SR, Denhardt DT, Noda M (1999) Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption.Proc Natl Acad Sci USA96: 8156–8160
Willing MC, Pruchno CJ, Atkinson M, Byers PH (1992) Osteogenesis imperfecta type I is commonly due to a COL1A1 null allele of type I collagen. AmJ Hum Genet51: 508–515
Chen D, Harris MA, Rossini G, Dunstan CR, Dallas SL, Feng JQ, Mundy GR, Harris SE (1997) Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts.Calcif Tissue Int60: 283–290
Fedde KN, Blair L, Silverstein J, Coburn SP, Ryan LM, Weinstein RS, Waymire K, Narisawa S, Millan JL, MacGregor GR et al (1999) Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia.J Bone Miner Res14: 2015–2026
Galvin KM, Donovan MJ, Lynch CA, Meyer RI, Paul RJ, Lorenz JN, Fairchild-Huntress V, Dixon KL, Dunmore JH, Gimbrone MA et al (2000) A role for smad6 in development and homeostasis of the cardiovascular system.Nat Genet24: 171–174
Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O’Reilly R, Bader BL, Hynes RO, Zhuang Y, Manova K et al (1999) Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts.Nature401: 670–677
Schorpp-Kistner M, Wang ZQ, Angel P, Wagner EF (1999) JunB is essential for mammalian placentation. EMBOJ18: 934–948
Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G (1997) Osf2, Cbfa1: a transcriptional activator of osteoblast differentiation.Cell89: 747–754
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Basel AG
About this chapter
Cite this chapter
Korchynsky, O., Dijke, P.t. (2002). Bone morphogenetic protein receptors and their nuclear effectors in bone formation. In: Vukicevic, S., Sampath, K.T. (eds) Bone Morphogenetic Proteins. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8121-0_3
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8121-0_3
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9446-3
Online ISBN: 978-3-0348-8121-0
eBook Packages: Springer Book Archive